[go: up one dir, main page]

AR132838A1 - Inhibidores de prmt5 y usos de los mismos - Google Patents

Inhibidores de prmt5 y usos de los mismos

Info

Publication number
AR132838A1
AR132838A1 ARP240101396A ARP240101396A AR132838A1 AR 132838 A1 AR132838 A1 AR 132838A1 AR P240101396 A ARP240101396 A AR P240101396A AR P240101396 A ARP240101396 A AR P240101396A AR 132838 A1 AR132838 A1 AR 132838A1
Authority
AR
Argentina
Prior art keywords
pharmaceutically acceptable
prmt5 inhibitors
stereoisomer
compound
acceptable salt
Prior art date
Application number
ARP240101396A
Other languages
English (en)
Inventor
Xiao Ding
Xiaoyu Ding
Hongfu Lu
Feng Ren
Meng Zhang
Original Assignee
Insilico Medicine Ip Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insilico Medicine Ip Ltd filed Critical Insilico Medicine Ip Ltd
Publication of AR132838A1 publication Critical patent/AR132838A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto de la fórmula (1), o una sal o estereoisómero farmacéuticamente aceptable del mismo. Una composición farmacéutica caracterizada porque comprende un compuesto de cualquiera de las reivindicaciones 1 - 35, o una sal o estereoisómero farmacéuticamente aceptable del mismo, y un portador o excipiente farmacéuticamente aceptable.
ARP240101396A 2023-06-02 2024-05-31 Inhibidores de prmt5 y usos de los mismos AR132838A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN2023098094 2023-06-02
CN2023133986 2023-11-24
CN2024071562 2024-01-10
CN2024091509 2024-05-07

Publications (1)

Publication Number Publication Date
AR132838A1 true AR132838A1 (es) 2025-08-06

Family

ID=93656693

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP240101396A AR132838A1 (es) 2023-06-02 2024-05-31 Inhibidores de prmt5 y usos de los mismos

Country Status (4)

Country Link
CN (1) CN121285551A (es)
AR (1) AR132838A1 (es)
TW (1) TW202513565A (es)
WO (1) WO2024245412A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250175331A (ko) 2023-04-21 2025-12-16 길리애드 사이언시즈, 인코포레이티드 Prmt5 억제제 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL302820A (en) * 2020-11-24 2023-07-01 Amgen Inc Tricyclic carboxamide derivatives as PRMT5 inhibitors
EP4288435A1 (en) * 2021-02-04 2023-12-13 Amgen Inc. Tricyclic-amido-bicyclic prmt5 inhibitors
CA3257612A1 (en) * 2022-07-15 2025-03-19 Abbisko Therapeutics Co., Ltd. PRMT5 INHIBITOR, ITS PREPARATION PROCESS AND PHARMACEUTICAL USE
CA3257212A1 (en) * 2022-08-03 2025-03-19 Abbisko Therapeutics Co., Ltd. Fused three-cycle PRMT5 inhibitor containing nitrogen, its preparation process and its pharmaceutical use

Also Published As

Publication number Publication date
WO2024245412A1 (en) 2024-12-05
TW202513565A (zh) 2025-04-01
CN121285551A (zh) 2026-01-06

Similar Documents

Publication Publication Date Title
AR133988A1 (es) Inhibidores de ras-pi3k y usos de los mismos
AR132007A1 (es) Compuestos y métodos para modular ras-pi3k
CO2022012975A2 (es) Derivados de biarilo como inhibidores de la interacción proteína-proteína de yap/taz-tead
AR128931A1 (es) Inhibidores del factor b del complemento y usos de los mismos
AR131639A1 (es) Inhibidores de kif18a y usos de los mismos
AR127501A1 (es) Inhibidores de la proteína que contiene el dominio de prolil hidroxilasa (phd) y usos de los mismos
AR128932A1 (es) Inhibidores de bcl-xl
AR134265A1 (es) Heterociclos y usos de los mismos
UY40235A (es) Compuestos de heteroarilo para el tratamiento del dolor
MX2022001743A (es) Formas en estado solido de (s)-2-(((s)-6,8-difluor-1,2,3,4-tetrahi dronaftalen-2-il)amino)-n-(1-(2-metil-1-(neopentilamino)propan-2- il)-1h-imidazol-4-il)pentanamida y usos de la misma.
AR132838A1 (es) Inhibidores de prmt5 y usos de los mismos
AR130602A1 (es) Inhibidores de tead y métodos de uso de los mismos
CL2025000529A1 (es) Compuestos derivados de dioxoisoquinolinona, inhibidores de ezh1 y/o ezh2; uso para tratar cáncer.
UY39727A (es) Inhibidores heteroaromáticos bicíclicos de la peptidasa 5 relacionada con la calicreína (klk5)
CO2026000093A2 (es) Composiciones farmacéuticas para inhibidores de la cinasa nek7
AR132983A1 (es) Inhibidores keap1 y usos de los mismos
CL2022002490A1 (es) Derivados de biarilo como inhibidores de la interacción proteína-proteína de yap/taz-tead
AR132166A1 (es) Inhibidores de inflamasoma nlrp3 y usos de los mismos
AR134204A1 (es) Nuevos compuestos como moduladores de los canales de sodio y usos de los mismos
AR132764A1 (es) Inhibidores de tyk2 y sus usos
AR130747A1 (es) Compuestos novedosos derivados de triciclo y usos de los mismos
AR130979A1 (es) Compuestos heterocilos y usos de los mismos
AR129588A1 (es) Inhibidores de kras
AR133115A1 (es) Inhibidores de kras
AR132055A1 (es) Inhibidores duales de cdk8/19 y métodos de uso de los mismos